An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpaAn employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa
An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa

In pandemic lesson, German drug maker Stada banks on China for raw materials, supply chain security

  • Stada seeking partnerships in mainland to bolster raw material supplies, sales in Asia’s biggest pharmaceutical market
  • Move in Asia follows recent aggressive acquisitions of assets in Russia, Ukraine markets
Topic |   Pharmaceuticals
An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpaAn employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa
An employee checks the production of capsules at a Stada Arzneimittel durg manufacturing facility in Germany. Photo: dpa
READ FULL ARTICLE